21 July 2025
Ropes & Gray Advises Gero in Chugai Pharmaceuticals Joint Research and License Agreement to Develop Novel Antibodies for Age-Related Diseases
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Hannah England Lead | Ropes & Gray | Partner | life sciences licensing | Not stated |
| Ian Nilsen Lead | Ropes & Gray | Associate | life sciences licensing | Not stated |
| Ryan Murphey | Ropes & Gray | Not stated | IP transactions | Not stated |
| Ben Ellington | Ropes & Gray | Associate | life sciences licensing | Not stated |
| Mallory Ursul | Ropes & Gray | Associate | life sciences licensing | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 250m ($250 million)
- What the figure measures
- Not stated
- Client
- Gero PTE. LTD.Joint venture party
- Counterparties
- Chugai Pharmaceutical Co, Ltd. (Joint venture party)